Illinois General Assembly - Bill Status for HB5517

Amends the Pharmacy Practice Act. In a provision concerning dispensing prescriptions, provides that if the physician or other authorized prescriber prescribes a specific generic drug, then the pharmacist must notify the patient or customer when he or she is dispensing a generic drug other than the specific generic drug prescribed. Provides that if a physician or other authorized prescriber changes a patient's prescription to a generic drug other than the specific drug that was originally prescribed, then the pharmacist must notify the patient or customer of this change at the time of dispensing that drug. Effective immediately.

Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. In a provision concerning dispensing prescriptions, provides that if the physician or other authorized prescriber prescribes a specific generic drug, then the pharmacist may not dispense a generic drug with a different active pharmaceutical ingredient. Provides that if the pharmacist receives verbal approval from the patient, then the pharmacist may dispense another generic drug with the same active pharmaceutical ingredient as the specific generic drug originally prescribed. Provides that if the original physician or other authorized prescriber changes a patient's prescription to a generic drug other than the specific drug that was originally prescribed by that physician or authorized prescriber, then the pharmacist must verbally notify the patient or customer of this change at the time of dispensing that drug and advise the patient or customer of his or her right to refuse the change. Effective immediately.

Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. In a provision concerning dispensing prescriptions, provides that if a physician or other authorized prescriber prescribes a drug and the pharmacy dispenses a generic, then it shall be the policy of every pharmacy operating in this State to require the pharmacist to notify the patient, patient's designee, or customer when he or she is dispensing a generic drug with the same active pharmaceutical ingredient by a different manufacturer than most recently previously dispensed for the patient by that pharmacy. Provides that the amendatory Act shall not be construed to affect the dispensing of drugs when the prescriber has marked "may not substitute" on the prescription form. Effective immediately.

×